Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes

OBJECTIVE: Insulin-dependent diabetes can occur with immune checkpoint inhibitor (ICI) therapy. We aimed to characterize the frequency, natural history and potential predictors of ICI-induced diabetes. RESEARCH DESIGN AND METHODS: We reviewed 1444 patients treated with ICIs over 6 years at our cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotwal, Anupam, Haddox, Candace, Block, Matthew, Kudva, Yogish C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Clinical Care/Education/Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398813/
https://www.ncbi.nlm.nih.gov/pubmed/30899528
http://dx.doi.org/10.1136/bmjdrc-2018-000591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398813/
https://www.ncbi.nlm.nih.gov/pubmed/30899528
http://dx.doi.org/10.1136/bmjdrc-2018-000591

Ejemplares similares